US EditionPublished • loading... • Updated
Dr Boreham’s Crucible: Nova Eye’s US vision sharpens as profits come into view
Summary by Stockhead
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Dr Boreham’s Crucible: Nova Eye’s US vision sharpens as profits come into view
With the bulk of its revenue now derived from the US, Adelaide-based glaucoma device maker Nova Eye Medical (ASX:EYE) would seem to be a bull’s eye target for the Trump administration’s punitive tariffs. In reality, Nova Eye is a poster child for the Make America Great Again (MAGA) manufacturing push, as it makes all its products at its facility at Fremont in San Francisco. What’s more, the company exports material from the US to Germany and Chi…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
